NSEAnalysts/Institutional Investor Meet/Con. Call Updates9 Jul 2026 · 9 Jul 2026, 06:13 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Amanta Healthcare Limited · AMANTA
✦ AI SummaryMgmt Change
Amanta Healthcare Limited has informed the Exchange about the outcome of its Investor/Analyst Meeting, where officials interacted with investors and analysts on July 9, 2026. The meeting was virtual, and no unpublished price sensitive information (UPSI) was discussed or shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Amanta Healthcare Limited has informed the Exchange about Schedule of meet and outcome
Attachments (1)
📄pdf
Download →
AMANTA_09072026181255_Intimation_of_outcome_of_Investor_Meeting.pdf
View document text
Registered & Corporate Office:
AMANTA HEALTHCARE LIMITED
8th Floor, Shaligram Corporates, CJ Marg,
Ambli, Ahmedabad–380058, Gujarat, INDIA.
Tel.: 079 – 67777600
Email: info@amanta.co.in
Website: www.amanta.co.in
CIN: L24139GJ1994PLC023944
July 9, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department National Stock Exchange of India Limited
BSE Limited Exchange Plaza, C-1, Block G
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051.
Scrip Code: 544502 Trading Symbol: AMANTA
Dear Sir/ Madam,
Sub: Outcome of Investor / Analyst Meeting
This has reference to our earlier intimation dated July 6, 2026 submitted pursuant to Regulation 30 of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the Investor /
Analyst Meeting.
In this regard, we would like to inform you that the officials of the Company interacted with Investor /
Analyst as per the details below:
Date Particulars of Investor Time Type of Meeting
Thursday, July 9, 2026 ValPro Capital 05:00 P.M. Virtual
During the interaction, the officials of the company shared publicly available information and no
Unpublished Price Sensitive Information (UPSI) was discussed or shared.
We request you to take the same on record.
Thanking you.
Yours sincerely,
For AMANTA HEALTHCARE LIMITED
NIKHITA DINODIA
COMPANY SECRETARY & COMPLIANCE OFFICER
Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720